NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study

BRAF V600E was detected by AS-PCR in bone marrow or EMD from 11 out of 209 patients (5.3%) with multiple myeloma (Table 1).. Two additional patients with positive BRAF V600E AS-PCR

Introduction Disease activity in patients with rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality, of which N-terminal pro-brain

NCT01832727 Oprozomib þ Dex I/II 128 Phase Ib/II, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Consolidation followed by maintenance therapy versus maintenance alone in newly diagnosed, transplant eligible patients with multiple myeloma (mm): a randomized phase 3 study of

Ixazomib-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not

Objectives: To investigate the long-term effect (week 16) of a 4-week rehabilitation programme for patients with rheumatoid arthritis (RA) and to compare the effect of this

Adalimumab: long- term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic

(2016) A Phase I/IIa study of the CD38 antibody MOR202 alone and in combina- tion with pomalidomide or lenalidomide in patients with relapsed or refractory multiple myeloma.